The treatment of gastric cancer is based on surgery, chemotherapy, radiotherapy and, lately, immunotherapy appears with greater force. pharmacogenetics, pharmacogenomics and epigenetics are beginning to be introduced in the management of neoplasms. In the case of gastric adenocarcinoma, what would be the main advance in the last two years?